Delivery Order SPE2DB20D3103-SPE2DB23FP1W2
Award Date 7/31/23
Potential Completion Date 8/21/23
Potential Value $5.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,806.66 firm fixed-price contract is for the supply of Envarsus XR 1 mg tablets, a specialty medication. The contract has a period of performance through February 25, 2025 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,711.95 firm fixed-price delivery order is for the supply of Envarsus XR 4 mg tablets, a medication used in organ transplant patients. The contract has an ultimate completion date of May 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,488.65 firm fixed-price contract provides Envarsus XR 4 mg tablets to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies globally. This delivery order is issued under that IDC, which...
- This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The delivery order is for Envarsus XR 4 mg tablets, a pharmaceutical product, with a firm fixed price of $1,615.33 and a completion date of November 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple IDCs by various federal agencies, including a $999,999,999 IDC with the DLA Troop Support...
- This is a delivery order award worth $6,461.32 to AmerisourceBergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA). The order is for the pharmaceutical product Envarsus XR 4 mg tablet, which is a critical medical supply. The contract has a completion date of September 27, 2024 and is a firm fixed-price contract. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the federal government, particularly the Department of Defense and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,711.95 firm-fixed-price contract is for the delivery of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of July 25, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order, valued at $1,615.33, is for the supply of the specialty medication Envarsus XR 4 mg tablet 100s. The delivery order has an ultimate completion date of April 8, 2024 and is not associated with any set-aside designations. Amerisourcebergen Drug Corp serves as a prime...
- The Defense Logistics Agency awarded a $1,288.86 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for 100 tablets of Envarsus XR 1 mg, a pharmaceutical product used in transplant immunosuppression therapy. This firm fixed price contract with an ultimate completion date of September 17, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.05 firm fixed-price delivery order is for ENVARSUS XR 1 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,000.81, is for the delivery of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product. The contract is a firm fixed-price delivery order without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...